Association Between Aortic Valve Sclerosis and Clonal Hematopoiesis of Indeterminate Potential
The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we investigated the effect of clonal hematopoiesis of indeterminate potential (CHIP) on the development of aortic valve sclerosis (AVS), a calcified aortic...
Saved in:
Published in | Annals of laboratory medicine Vol. 44; no. 3; pp. 279 - 288 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
대한진단검사의학회
01.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we investigated the effect of clonal hematopoiesis of indeterminate potential (CHIP) on the development of aortic valve sclerosis (AVS), a calcified aortic valve without significant stenosis.
Participants with AVS (valves ≥2 mm thick, high echogenicity, and a peak transaortic velocity of <2.5 m/sec) and an age- and sex-matched control group were enrolled. Twenty-four CHIP genes with common variants in cardiovascular disease were used to generate a next-generation sequencing panel. The primary endpoint was the CHIP detection rate between the AVS and control groups. Inverse-probability treatment weighting (IPTW) analysis was performed to adjust for differences in baseline characteristics.
From April 2020 to April 2022, 187 participants (125 with AVS and 62 controls) were enrolled; the mean age was 72.6±8.5 yrs, and 54.5% were male. An average of 1.3 CHIP variants was observed. CHIP detection, defined by a variant allele frequency (VAF) of ≥0.5%, was similar between the groups. However, the AVS group had larger CHIP clones: 49 (39.2%) participants had a VAF of ≥1% (vs. 13 [21.0%] in the control group;
=0.020), and 25 (20.0%) had a VAF of ≥2% (vs. 4 [6.5%];
=0.028). AVS is independently associated with a VAF of ≥1% (adjusted odds ratio: 2.44, 95% confidence interval: 1.11-5.36;
=0.027). This trend was concordant and clearer in the IPTW cohort.
Participants with AVS more commonly had larger CHIP clones than age- and sex-matched controls. Further studies are warranted to identify causality between AVS and CHIP. |
---|---|
AbstractList | Background: The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we investigated the effect of clonal hematopoiesis of indeterminate potential (CHIP) on the development of aortic valve sclerosis (AVS), a calcified aortic valve without significant stenosis.
Methods: Participants with AVS (valves ≥2 mm thick, high echogenicity, and a peak transaortic velocity of <2.5 m/sec) and an age- and sex-matched control group were enrolled. Twenty-four CHIP genes with common variants in cardiovascular disease were used to generate a next-generation sequencing panel. The primary endpoint was the CHIP detection rate between the AVS and control groups. Inverse-probability treatment weighting (IPTW) analysis was performed to adjust for differences in baseline characteristics.
Results: From April 2020 to April 2022, 187 participants (125 with AVS and 62 controls) were enrolled; the mean age was 72.6±8.5 yrs, and 54.5% were male. An average of 1.3 CHIP variants was observed. CHIP detection, defined by a variant allele frequency (VAF) of ≥0.5%, was similar between the groups. However, the AVS group had larger CHIP clones: 49 (39.2%) participants had a VAF of ≥1% (vs. 13 [21.0%] in the control group; P=0.020), and 25 (20.0%) had a VAF of ≥2% (vs. 4 [6.5%]; P=0.028). AVS is independently associated with a VAF of ≥1% (adjusted odds ratio: 2.44, 95% confidence interval: 1.11–5.36; P=0.027). This trend was concordant and clearer in the IPTW cohort.
Conclusions: Participants with AVS more commonly had larger CHIP clones than age- and sex-matched controls. Further studies are warranted to identify causality between AVS and CHIP. KCI Citation Count: 0 BackgroundThe mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we investigated the effect of clonal hematopoiesis of indeterminate potential (CHIP) on the development of aortic valve sclerosis (AVS), a calcified aortic valve without significant stenosis.MethodsParticipants with AVS (valves ≥2 mm thick, high echogenicity, and a peak transaortic velocity of <2.5 m/sec) and an age- and sex-matched control group were enrolled. Twenty-four CHIP genes with common variants in cardiovascular disease were used to generate a next-generation sequencing panel. The primary endpoint was the CHIP detection rate between the AVS and control groups. Inverse-probability treatment weighting (IPTW) analysis was performed to adjust for differences in baseline characteristics.ResultsFrom April 2020 to April 2022, 187 participants (125 with AVS and 62 controls) were enrolled; the mean age was 72.6±8.5 yrs, and 54.5% were male. An average of 1.3 CHIP variants was observed. CHIP detection, defined by a variant allele frequency (VAF) of ≥0.5%, was similar between the groups. However, the AVS group had larger CHIP clones: 49 (39.2%) participants had a VAF of ≥1% (vs. 13 [21.0%] in the control group; P=0.020), and 25 (20.0%) had a VAF of ≥2% (vs. 4 [6.5%]; P=0.028). AVS is independently associated with a VAF of ≥1% (adjusted odds ratio: 2.44, 95% confidence interval: 1.11-5.36; P=0.027). This trend was concordant and clearer in the IPTW cohort.ConclusionsParticipants with AVS more commonly had larger CHIP clones than age- and sex-matched controls. Further studies are warranted to identify causality between AVS and CHIP. The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we investigated the effect of clonal hematopoiesis of indeterminate potential (CHIP) on the development of aortic valve sclerosis (AVS), a calcified aortic valve without significant stenosis. Participants with AVS (valves ≥2 mm thick, high echogenicity, and a peak transaortic velocity of <2.5 m/sec) and an age- and sex-matched control group were enrolled. Twenty-four CHIP genes with common variants in cardiovascular disease were used to generate a next-generation sequencing panel. The primary endpoint was the CHIP detection rate between the AVS and control groups. Inverse-probability treatment weighting (IPTW) analysis was performed to adjust for differences in baseline characteristics. From April 2020 to April 2022, 187 participants (125 with AVS and 62 controls) were enrolled; the mean age was 72.6±8.5 yrs, and 54.5% were male. An average of 1.3 CHIP variants was observed. CHIP detection, defined by a variant allele frequency (VAF) of ≥0.5%, was similar between the groups. However, the AVS group had larger CHIP clones: 49 (39.2%) participants had a VAF of ≥1% (vs. 13 [21.0%] in the control group; =0.020), and 25 (20.0%) had a VAF of ≥2% (vs. 4 [6.5%]; =0.028). AVS is independently associated with a VAF of ≥1% (adjusted odds ratio: 2.44, 95% confidence interval: 1.11-5.36; =0.027). This trend was concordant and clearer in the IPTW cohort. Participants with AVS more commonly had larger CHIP clones than age- and sex-matched controls. Further studies are warranted to identify causality between AVS and CHIP. |
Author | Kim, Jin Ju Lee, Hyeonah Lee, Seung-Tae Shim, Yeeun Bae, SungA Jung, In Hyun Kim, Minkwan Son, Nak-Hoon Shin, Saeam |
Author_xml | – sequence: 1 givenname: Minkwan orcidid: 0000-0002-4079-8219 surname: Kim fullname: Kim, Minkwan organization: Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine and Cardiovascular Center, Yongin, Korea – sequence: 2 givenname: Jin Ju orcidid: 0000-0001-9166-1848 surname: Kim fullname: Kim, Jin Ju organization: Department of Laboratory Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea – sequence: 3 givenname: Seung-Tae orcidid: 0000-0003-1047-1415 surname: Lee fullname: Lee, Seung-Tae organization: Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea – sequence: 4 givenname: Yeeun orcidid: 0000-0001-7131-3619 surname: Shim fullname: Shim, Yeeun organization: Department of Laboratory Medicine, Graduate School of Medical Sciences, Brain Korea 21 PLUS Project, Yonsei University College of Medicine, Seoul, Korea – sequence: 5 givenname: Hyeonah orcidid: 0000-0002-8164-1947 surname: Lee fullname: Lee, Hyeonah organization: Department of Laboratory Medicine, Graduate School of Medical Sciences, Brain Korea 21 PLUS Project, Yonsei University College of Medicine, Seoul, Korea – sequence: 6 givenname: SungA orcidid: 0000-0003-1484-4645 surname: Bae fullname: Bae, SungA organization: Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine and Cardiovascular Center, Yongin, Korea – sequence: 7 givenname: Nak-Hoon orcidid: 0000-0002-6192-8852 surname: Son fullname: Son, Nak-Hoon organization: Department of Statistics, Keimyung University, Korea – sequence: 8 givenname: Saeam orcidid: 0000-0003-1501-3923 surname: Shin fullname: Shin, Saeam organization: Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea – sequence: 9 givenname: In Hyun orcidid: 0000-0002-1793-215X surname: Jung fullname: Jung, In Hyun organization: Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine and Cardiovascular Center, Yongin, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38205526$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003072965$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNo9kUFvEzEQhS1UREvpkSvyESFt8I69u9ljiCiNVImqFI5YE-8YmXrtYDsg_n0dUjqXN9J886SZ95KdhBiIsdetWEip5Hv08wIEyIWAfvmMnQFI1chlq06eetGfsoucf4pavWhhFC_YqVyC6Droz9j3Vc7ROCwuBv6Byh-iwFcxFWf4N_S_iX8xnlLMLnMME1_7GNDzK5qxxF10dBhEyzdhokJpdgEL8ZtYKBSH_hV7btFnunjUc_b18uPd-qq5_vxps15dN0aCLA3iuDU0wTSBoK0SBHKyA5qtse1oFKCZ-mEEaQejqN4AvZJkVduRGUCglefs3dE3JKvvjdMR3T_9EfV90qvbu41uhap7g6jw2yO8S_HXnnLRs8uGvMdAcZ81jK1UXQuqq2hzRE19QU5k9S65GdPf6qYPEegagT5EoA8RVP7No_V-O9P0RP9_uHwAw2aECA |
Cites_doi | 10.1093/clinchem/hvac146 10.1016/j.jacc.2003.08.036 10.1056/NEJMoa1408617 10.1016/S0140-6736(06)69208-8 10.1136/hrt.67.3.236 10.1253/circj.CJ-18-0871 10.1126/science.aag1381 10.1056/NEJMoa1109034 10.1056/NEJMoa1701719 10.1038/s41436-021-01138-5 10.1053/j.ajkd.2007.05.020 10.1161/CIRCULATIONAHA.121.053708 10.1182/blood-2011-11-394775 10.1097/MJT.0b013e3181a2b1a6 10.1016/j.jacc.2017.12.037 10.1093/ehjci/jeu184 10.1001/jamacardio.2022.0386 10.1161/CIRCRESAHA.118.313225 10.1136/hrt.2004.057117 10.1097/00001648-200009000-00011 10.1001/jamacardio.2020.2468 10.1073/pnas.1506264112 10.3343/alm.2023.43.2.145 10.1016/S0140-6736(22)00916-3 10.1002/ehf2.13297 10.1182/bloodadvances.2018020222 10.1182/blood-2015-03-631747 10.3343/alm.2019.39.6.509 10.1182/blood-2017-02-769869 10.1016/j.ijcard.2018.01.054 10.1161/CIRCRESAHA.120.317104 10.1016/j.jmoldx.2016.10.002 10.1016/j.jcmg.2011.12.023 10.1097/00007611-199501000-00009 10.1093/bioinformatics/btr597 10.1093/eurheartj/ehz591 10.1016/j.jacc.2014.04.018 10.1016/j.echo.2014.10.003 10.1161/CIRCULATIONAHA.115.016757 |
ContentType | Journal Article |
DBID | NPM AAYXX CITATION 7X8 ACYCR |
DOI | 10.3343/alm.2023.0268 |
DatabaseName | PubMed CrossRef MEDLINE - Academic Korean Citation Index (Open Access) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-3814 |
EndPage | 288 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10426470 10_3343_alm_2023_0268 38205526 |
Genre | Journal Article |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL C~G DIK DYU ECGQY EF. EMOBN GX1 KQ8 M48 M~E NPM OK1 PGMZT RPM AAYXX CITATION 7X8 ADRAZ HYE OZF |
ID | FETCH-LOGICAL-c323t-aa9bced2dd20eb40e23df7acbcf19c42acd67923f7c4e1292643ef415ec720af3 |
IEDL.DBID | M48 |
ISSN | 2234-3806 |
IngestDate | Fri Apr 26 03:28:05 EDT 2024 Sat Aug 17 03:27:39 EDT 2024 Fri Aug 23 01:32:25 EDT 2024 Wed Oct 09 10:35:57 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Inflammation Variant allele frequency Aortic valve sclerosis High-throughput nucleotide sequencing Clonal hematopoiesis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c323t-aa9bced2dd20eb40e23df7acbcf19c42acd67923f7c4e1292643ef415ec720af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7131-3619 0000-0003-1484-4645 0000-0002-4079-8219 0000-0002-6192-8852 0000-0002-8164-1947 0000-0001-9166-1848 0000-0003-1501-3923 0000-0003-1047-1415 0000-0002-1793-215X |
OpenAccessLink | https://www.annlabmed.org/journal/download_pdf.php?doi=10.3343/alm.2023.0268 |
PMID | 38205526 |
PQID | 2913451245 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10426470 proquest_miscellaneous_2913451245 crossref_primary_10_3343_alm_2023_0268 pubmed_primary_38205526 |
PublicationCentury | 2000 |
PublicationDate | 2024-May-01 2024-05-01 20240501 2024-05 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: 2024-May-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Annals of laboratory medicine |
PublicationTitleAlternate | Ann Lab Med |
PublicationYear | 2024 |
Publisher | 대한진단검사의학회 |
Publisher_xml | – name: 대한진단검사의학회 |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – ident: ref17 doi: 10.1093/clinchem/hvac146 – ident: ref34 doi: 10.1016/j.jacc.2003.08.036 – ident: ref3 doi: 10.1056/NEJMoa1408617 – ident: ref7 doi: 10.1016/S0140-6736(06)69208-8 – ident: ref36 doi: 10.1136/hrt.67.3.236 – ident: ref16 doi: 10.1253/circj.CJ-18-0871 – ident: ref26 doi: 10.1126/science.aag1381 – ident: ref32 doi: 10.1056/NEJMoa1109034 – ident: ref2 doi: 10.1056/NEJMoa1701719 – ident: ref19 doi: 10.1038/s41436-021-01138-5 – ident: ref37 doi: 10.1053/j.ajkd.2007.05.020 – ident: ref38 doi: 10.1161/CIRCULATIONAHA.121.053708 – ident: ref25 doi: 10.1182/blood-2011-11-394775 – ident: ref39 doi: 10.1097/MJT.0b013e3181a2b1a6 – ident: ref4 doi: 10.1016/j.jacc.2017.12.037 – ident: ref12 doi: 10.1093/ehjci/jeu184 – ident: ref27 doi: 10.1001/jamacardio.2022.0386 – ident: ref5 doi: 10.1161/CIRCRESAHA.118.313225 – ident: ref8 doi: 10.1136/hrt.2004.057117 – ident: ref21 doi: 10.1097/00001648-200009000-00011 – ident: ref29 doi: 10.1001/jamacardio.2020.2468 – ident: ref11 – ident: ref22 doi: 10.1073/pnas.1506264112 – ident: ref23 doi: 10.3343/alm.2023.43.2.145 – ident: ref40 doi: 10.1016/S0140-6736(22)00916-3 – ident: ref30 doi: 10.1002/ehf2.13297 – ident: ref15 doi: 10.1182/bloodadvances.2018020222 – ident: ref1 doi: 10.1182/blood-2015-03-631747 – ident: ref14 doi: 10.3343/alm.2019.39.6.509 – ident: ref24 doi: 10.1182/blood-2017-02-769869 – ident: ref9 doi: 10.1016/j.ijcard.2018.01.054 – ident: ref28 doi: 10.1161/CIRCRESAHA.120.317104 – ident: ref18 doi: 10.1016/j.jmoldx.2016.10.002 – ident: ref33 doi: 10.1016/j.jcmg.2011.12.023 – ident: ref35 doi: 10.1097/00007611-199501000-00009 – ident: ref20 doi: 10.1093/bioinformatics/btr597 – ident: ref6 doi: 10.1093/eurheartj/ehz591 – ident: ref10 doi: 10.1016/j.jacc.2014.04.018 – ident: ref13 doi: 10.1016/j.echo.2014.10.003 – ident: ref31 doi: 10.1161/CIRCULATIONAHA.115.016757 |
SSID | ssj0000601290 |
Score | 2.360179 |
Snippet | The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we... BackgroundThe mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we... Background: The mechanism and medical treatment target for degenerative aortic valve disease, including aortic stenosis, is not well studied. In this study, we... |
SourceID | nrf proquest crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 279 |
SubjectTerms | 병리학 |
Title | Association Between Aortic Valve Sclerosis and Clonal Hematopoiesis of Indeterminate Potential |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38205526 https://search.proquest.com/docview/2913451245 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003072965 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Annals of Laboratory Medicine, 2024, 44(3), , pp.279-288 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS9xAEF_0hNIX8bNeW2WLpW-xud3N10ORU5SzcCK0J_riMtkPEUOid1H0v3fG5NSiBZ8SSHY3_HaS-f0ys7OMfQ9B2iQ1MohVHgUKoBdkBpIgRrUVZhYiH9Fq5OFhPBip3yfRyXNJoRbAyZvSjvaTGo2Lrbvr-2184X-R4pRK_oSClpQLuYV6Ip1lc0JJRcY-bJl-81Ge_nFBf6gCmYZxU3HzdQ__eKjZcuz_Tz4fndD-Aptv2SPvN9O9yGZcucQ-DNv4-DI7e4E232lSsHi_otv5MRS3jv_BdjjsxYRDafluQUScD6hwa3VVoWrGC5XnB6WdpsnUjh9VNeUUQbHCRvt7f3cHQbuDQmCkkHUAkOXGWWGtCF2uQiek9QmY3PheZpQAY2MqIOgToxzig-xIOo8-3ZlEhODlKuuUVenWGHdJlqJYhJ4gDeZsKnJPYes4BOzfRV32Y4qavmoKZWgUGASvRng1wasJ3i7bREz1pbnQVNqajueVvhxrJPAH2IQoWhJ22bcp5hoNnqIYULrqZqIF5QogTVE45KdmMp4GlMhnokjEn9_7MF_YRzxXTQbjV9apxzduHVlGnW8gvz4dbTxa0QPfg89B |
link.rule.ids | 315,786,790,2236,24346,27957,27958 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+Between+Aortic+Valve+Sclerosis+and+Clonal+Hematopoiesis+of+Indeterminate+Potential&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Kim%2C+Minkwan&rft.au=Kim%2C+Jin+Ju&rft.au=Lee%2C+Seung-Tae&rft.au=Shim%2C+Yeeun&rft.date=2024-05-01&rft.issn=2234-3806&rft.eissn=2234-3814&rft.volume=44&rft.issue=3&rft.spage=279&rft.epage=288&rft_id=info:doi/10.3343%2Falm.2023.0268&rft.externalDBID=n%2Fa&rft.externalDocID=10_3343_alm_2023_0268 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon |